85629-99-8

Basic information

• Product Name: 5-[2-Bromo-5-(4-methoxycarbonyl-4-methyl-pentyloxy)-phenoxy]-2,2-dimethyl-pentanoic acid methyl ester
• Synonyms: 5-[2-Bromo-5-(4-methoxycarbonyl-4-methyl-pentyloxy)-phenoxy]-2,2-dimethyl-pentanoic acid methyl ester
• CAS NO: 85629-99-8
• Molecular Weight: 473.404
• Mol File: 85629-99-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 5-[2-Bromo-5-(4-methoxycarbonyl-4-methyl-pentyloxy)-phenoxy]-2,2-dimethyl-pentanoic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 5-[2-Bromo-5-(4-methoxycarbonyl-4-methyl-pentyloxy)-phenoxy]-2,2-dimethyl-pentanoic acid methyl ester(85629-99-8)
• EPA Substance Registry System: 5-[2-Bromo-5-(4-methoxycarbonyl-4-methyl-pentyloxy)-phenoxy]-2,2-dimethyl-pentanoic acid methyl ester(85629-99-8)

Safety Data

• Hazardous Substances Data: 85629-99-8(Hazardous Substances Data)

Upstream product

• 6626-15-9 4-Bromoresorcinol 
• 79520-52-8 5-Bromo-2,2-dimethylpentanoic acid,methyl ester 

Relevant articles and documents

Phenylenebis(oxy)bis[2,2-dimethylpentanoic acid]s: Agents that elevate high-density lipoproteins

A series of phenylenebis(oxy)bis[2,2-dimethylpentanoic acid]s have been synthesized and evaluated as potential hypolipidemic agents. Compound 18 (CI-924) was found to be the most potent compound in this series. In rats, compound 18 is not only reduced low-density lipoprotein cholesterol but also increased high-density lipoprotein (HDL cholesterol. Comparative studies in rats indicated 18 produced an equal elevation of HDL cholesterol at one-third of the dose required of gemfibrozil. Structure-activity relationships are discussed.